A new method for crystalloid cardioplegic oxygenation | Canada Hyperbarics Skip to main content
Study Perfusion 1991

A new method for crystalloid cardioplegic oxygenation

Staffan G, Svenmarker P, Häggmark S, Jansson K — Perfusion, 1991

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers tested a new way to add oxygen to heart-protecting solutions by placing Ringer's infusion bags in a high-pressure oxygen environment of 380mmHg.

What They Found

Oxygen diffused through the bag walls, reaching over four volumes percent concentration after 96 hours. The oxygen content remained stable, with less than 1.5% decay after one week when refrigerated at 4 degrees C.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was conducted in a laboratory setting and did not involve human or animal subjects, limiting its direct applicability to patient care.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 10149502
Year Published 1991
Journal Perfusion
MeSH Terms Cardioplegic Solutions; Humans; Hyperbaric Oxygenation; Membranes, Artificial; Temperature

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.